Journal of Materials Science: Materials in Medicine (2021) 32:26
TISSUE ENGINEERING CONSTRUCTS AND CELL SUBSTRATES
SDF-1αgene-activated collagen scaffold enhances provasculogenic
response in a coculture of human endothelial cells with human
adipose-derived stromal cells
Ashang L. Laiva 1,2 ●Fergal J. O’Brien1,3,4 ●Michael B. Keogh1,2
Received: 15 June 2020 / Accepted: 17 February 2021 / Published online: 6 March 2021
© The Author(s) 2021
Novel biomaterials can be used to provide a better environment for cross talk between vessel forming endothelial cells and
wound healing instructor stem cells for tissue regeneration. This study seeks to investigate if a collagen scaffold containing a
proangiogenic gene encoding for the chemokine stromal-derived factor-1 alpha (SDF-1αGAS) could be used to enhance
functional responses in a coculture of human umbilical vein endothelial cells (HUVECs) and human adipose-derived stem/
stromal cells (ADSCs). Functional responses were determined by (1) monitoring the amount of junctional adhesion molecule
VE-cadherin released during 14 days culture, (2) expression of provasculogenic genes on the 14th day, and (3) the
bioactivity of secreted factors on neurogenic human Schwann cells. When we compared our SDF-1αGAS with a gene-free
scaffold, the results showed positive proangiogenic determination characterized by a transient yet controlled release of the
VE-cadherin. On the 14th day, the coculture on the SDF-1αGAS showed enhanced maturation than its gene-free equivalent
through the elevation of provasculogenic genes (SDF-1α—7.4-fold, CXCR4—1.5-fold, eNOS—1.5-fold). Furthermore, we
also found that the coculture on SDF-1αGAS secretes bioactive factors that signiﬁcantly (p< 0.01) enhanced human
Schwann cells’clustering to develop toward Bünger band-like structures. Conclusively, this study reports that SDF-1αGAS
could be used to produce a bioactive vascularized construct through the enhancement of the cooperative effects between
endothelial cells and ADSCs.
*Michael B. Keogh
1Tissue Engineering Research Group, Department of Anatomy and
Regenerative Medicine, Royal College of Surgeons in Ireland, 123
St. Stephen’s Green, Dublin 2, Ireland
2Department of Biomedical Science, Royal College of Surgeons in
Ireland, Adliya, Bahrain
3Trinity Centre for Bioengineering, Trinity Biomedical Sciences
Institute, Trinity College Dublin, Dublin 2, Ireland
4Advanced Materials and Bioengineering Research Centre, Royal
College of Surgeons in Ireland and Trinity College Dublin,
Insufﬁcient regeneration of a vascular network remains one
of the major limitations of biomaterials scaffolds used in
wound healing . To overcome this problem, functiona-
lizing the scaffolds with either natural or synthetic proan-
giogenic growth factors to promote local angiogenesis is a
popular strategy [2–5]. These scaffolds are designed to
generate a gradient of growth factors to stimulate vessel
growth toward the desired site and promote their maturation
. However, there is a lack of general consensus on the
optimal dose of growth factors to be delivered. In addition,
these angiogenic factors are susceptible to proteolysis, while
bolus delivery of high doses to sustain the therapeutic effect
raises the risk of toxicity as well as cost . Parallel
investigations such as prevascularizing biomaterial scaf-
folds using endothelial cells show potential [8–10]. Appli-
cation of these prevascularized scaffolds is expected to
signiﬁcantly promote biomaterial integration as well as
accelerate vascular regeneration by anastomising with host
vessels [11,12]. However, maintaining the stability of the
vascular structure within the scaffold remains an important
developmental criteria for therapeutic success. Conse-
quently, strategies aiming at improving the stability of the
endothelial network while allowing adequate angiogenesis
continues to be investigated [13,14].
One of the strategies adopted in our group for enhancing
the stability of the endothelial network is the delayed
addition of stem cells to a preformed endothelial network.
This approach has also been found to enhance vascular-
ization in vivo . Having observed the importance of
cross talk between endothelial cells and stem cells, we
hypothesized that the endothelial cells could be activated to
recruit surrounding stem cells and enhance their interac-
tion. Biomaterial scaffolds functionalised with therapeutic
genes, called the gene-activated scaffolds (GAS), are an
effective platform for activating cells. It works by inducing
overexpression of the therapeutic protein by the cells,
eventually aiding in enhancing the regenerative capacity of
the scaffold [15–17].
Our group focuses in the development of nonviral based
GAS through the use of nonviral vectors such as poly-
ethyleneimine (PEI) [16,18,19]. Using this vector-based
GAS, we have shown that the delivery of a proangiogenic
gene stromal-derived factor-1 alpha (SDF-1α) to mesench-
ymal stem cells (MSCs) signiﬁcantly potentiates its angio-
genic action on endothelial cells . Moreover, SDF-1αis
a potent chemokine upregulated during the early stages of
wound healing. It is crucial for the homing of endothelial
progenitor cells to ischemic sites and promote local angio-
genesis [21–24]. Therefore, in this study, we seek to
investigate if the SDF-1αGAS could be used to enhance the
provasculogenic maturation of cocultures of endothelial cells
and adipose-derived stem/stromal cells (ADSCs). The pre-
vious study  from our group used human bone marrow
MSCs to reinforce the endothelial network. However, in our
study, we seek to use human stem/stromal cells derived from
the adipose tissue (ADSCs) because of the relative abun-
dance of bone marrow MSCs, ease of isolation, and good
patient compliance . Several studies have also shown
that ADSCs possess strong vasculogenic properties as well
as demonstrate great potential for enhancing vascularization
of various scaffolds by endothelial cells [25–29].
Nevertheless, in addition to vasculogenesis, neuronal
regeneration is an important aspect of wound healing that is
often overlooked. Schwann cells (SCs) are the key media-
tors of neurogenesis . During angiogenesis, the angio-
genic vessels guide the SCs to the site of wound . The
SCs then lay down matrix to guide regenerating axons and
promote their reinnervation of the epidermis . More-
over, SCs also possess the ability to provide contact gui-
dance to endothelial cells and direct their morphogenesis
toward a proangiogenic growth .
Therefore, the speciﬁc aims of this study are to deter-
mine if (1) the transfection of SDF-1αgene induces the
secretion of SDF-1αproteins by human endothelial cells
and that the protein possess chemotactic activity on human
ADSCs; (2) SDF-1αGAS can support angiogenesis and
promote provasculogenic response in endothelial cells and
its coculture with ADSCs; and ultimately if (3) the vas-
cularized construct can signal human SCs toward a pro-
2 Materials and methods
2.1 Plasmid propagation and preparation of
Plasmid DNA (pDNA) encoding for the therapeutic gene
SDF-1α(pSDF-1α) was obtained from InvivoGen, San
Diego, USA. The plasmids were ﬁrst ampliﬁed by trans-
forming chemically competent DH5αE. coli cells (Bios-
ciences, Ireland) according to the manufacturer’s protocol.
Transformed cells were then expanded in lysogeny broth
(LB) plates containing 100 μg/ml of blasticidin as the
selective antibiotic for pSDF-1α. After 24 h at 37 °C, bac-
terial colonies were harvested and ampliﬁed in LB broth
containing the appropriate antibiotic and cultured overnight
in a shaker incubator at 37 °C. Plasmid puriﬁcation was
performed using a QIAGEN®EndoFree®Plasmid Maxi kit
(Qiagen, Sussex, UK) and ﬁnal nucleic acid concentration
was determined using NanoDrop 1000 spectroscopy. Plas-
mids were further diluted in TE buffer to obtain a working
concentration of 0.5 μg/μl and stored at −20 °C until use.
pDNA encoding a nontherapeutic Gaussia luciferase (pLuc)
26 Page 2 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
purchased from New England Biolabs, Massachusetts,
USA, was similarly ampliﬁed using ampicillin as the
selective antibiotic. Based on our previous study, polyplex
particles were formulated by initially mixing a speciﬁed
amount of branched cationic 25 kDa PEI (Sigma-Aldrich,
Ireland) and anionic pDNA (ﬁxed at a dose of 2 μg) to give
an N/P ratio of 10.
2.2 Expansion and transfection of cells
Human umbilical vein endothelial cells (HUVECs) and
ADSCs were obtained from Cell Applications, Inc. and
iXCells Biotechnologies, USA, respectively. HUVECs
were cultured in supplemented EndoGRO media (EGM-2;
Merck Millipore, USA) without VEGF (EGM−VEGF) and
expanded to passage 4 for all experiments. ADSCs were
expanded in 1:1 Dulbecco’s Modiﬁed Eagles Medium/
Nutrient mixture F-12 (D8437, Sigma-Aldrich, UK) sup-
plemented with 10% FBS (Gibco, UK), 2% penicillin/
streptomycin (Sigma-Aldrich, UK), and 1% amphotericin B
(Gibco, UK) and harvested at passage 5 for subsequent
experiments. The HUVECs were seeded at a density of 5 ×
104cells per well in six-well adherent plates (Corning,
Costar, UK) 24 h prior to transfection. One hour prior to
transfection, the media were removed and replaced with
Opti-MEM (Gibco, UK). Meanwhile, PEI was mixed with a
2 µg dose of pDNA at an N/P ratio of 10 and was allowed to
assemble into polyplex by electrostatic interaction for
30 min. The PEI–pDNA polyplexes were then suspended in
Opti-MEM and added to the monolayer and incubated at
37 °C for 15 min. After 15 min, an additional 1 ml of Opti-
MEM was added and the cells were incubated for ~4 h.
After this transfection period, the medium was removed and
the cell monolayer was rinsed with PBS. EGM−VEGF was
then added and the cells were incubated at 37 °C to allow
expression of the transgene. Media change was performed
by collecting 1 ml of the media (conditioned media (CM))
and replacing it with fresh media at 3, 7, 10, and 14 days.
All CM were stored at −80 °C until analysis.
2.3 Effect of transfection on viability of cells
To determine the effect of therapeutic gene transfer on the
transfected cell, cell viability following transfection with
PEI–pSDF-1αor PEI–pLuc was assessed using the colori-
metric MTS assay (CellTiter 96®AQueous One Solution,
Promega, Madison, WI, USA). Brieﬂy at 1, 3, and 7 days
post transfection, 20 μl of the MTS reagent was added to the
cells in 100 μl of media, and incubated for 4 h at 37 °C.
Intensity of the resulting color was measured at an absor-
bance of 490 nm using a Multiskan GO plate reader
(Thermo Scientiﬁc, UK). Cell viability percentage (%) was
determined according to the equation (absorbance[transfected]/
absorbance[control]) × 100, keeping the untransfected cells as
100% viability control.
2.4 ELISA for quantiﬁcation of SDF-1αprotein
production post transfection in 2D culture
In order to determine successful transfection of pSDF-1α,
secretion of SDF-1αproteins into the culture medium was
determined using a human SDF-1αspeciﬁc ELISA kit
(DY350, R&D Systems, UK) according to the manu-
facturer’s instructions. One hundred microliters of CM
collected from days 3, 7, 10, and 14 were used for the assay
and the absorbance was read at 450 nm using a Multiskan
GO plate reader (Thermo Scientiﬁc, UK) whereby the
quantity of SDF-1αprotein present was deduced by calcu-
lating against a standard curve.
2.5 Coculture of HUVECs and ADSCs in a 2D setup
In order to assess the functionality of secreted proteins, a
delayed addition approach previously reported by our group
 was adopted where stem cells are added onto preseeded
HUVECs. Based on the previous study , the ratio of
HUVECs to the ADSCs was set at 4:1. The transfection
experiment was performed as in the section “Expansion and
transfection of cells,”except that HUVECs were initially
seeded at a density of 4 × 104and allowed to grow until the
3rd day, after which 1 × 104ADSCs were added. On the
14th day of incubation, images of the cocultures were
captured using a Celestron®digital microscope imager,
attached to a phase-contrast Olympus CKX31 microscope.
CM was also collected from these groups as described in the
section “Expansion and transfection of cells,”to analyze
how the expression of SDF-1αis affected by the addition of
ADSCs. All the cocultures were maintained in EGM−VEGF.
2.6 Cell seeding on SDF-1αGAS
SDF-1αGAS was developed as described earlier ,
which basically involves soak-loading of the PEI–pSDF-1α
polyplex nanoparticles into a freeze-dried porous 3D coll-
CS scaffold . For this study, a double-sided cell seeding
of equal cellular density was performed. For culture of
HUVECs alone, a total of 5 × 105cells were seeded onto the
scaffold/SDF-1αGAS, while for coculture groups, 4 × 105
HUVECs were initially seeded and allowed to endothelia-
lize the scaffolds/SDF-1αGAS for 3 days before 1 × 105
ADSCs were added onto it . Consequently, four groups
were developed (1) HUVECs alone on gene-free scaffold,
(2) HUVECs alone on SDF-1αGAS, (3) coculture on gene-
free scaffold, and (4) coculture on SDF-1αGAS. For initial
transfection of HUVECs in the SDF-1αGAS, 2 ml of
Opti-MEM was added and the plates were incubated at
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 3 of 13 26
37 °C for 24 h after which the media were removed and
replaced with 2 ml of EGM−VEGF. To assay the temporal
regulation of soluble vascular molecules, media were col-
lected and replaced in the same manner as described pre-
viously in the section “Expansion and transfection of cells.”
2.6.1 ELISA for quantiﬁcation of soluble vascular
endothelial cadherin (VE-cadherin) and VCAM-1 in
To determine angiogenic growth of the endothelial cultures
in SDF-1αGAS, secretion of the soluble forms of endo-
thelial junctional adhesion molecule VE-cadherin (DY938,
R&D Systems, UK) and inﬂammation induced transmem-
brane molecule VCAM-1 (DY809, R&D Systems, UK) was
analyzed. To assay angiogenesis, 100 μl of CM collected
from days 3, 7, 10, and 14 were used for the assay and the
absorbance was read at 450 nm using a Multiskan GO plate
reader (Thermo Scientiﬁc, UK). The quantity of soluble
VE-cadherin or VCAM-1 released was deduced by calcu-
lating against their respective standard curves.
2.6.2 qRT-PCR analysis to determine functional gene
expression in endothelialized SDF-1αGAS
Cells from the scaffolds were harvested on the 14th day for
gene expression analysis. RNA extraction and reverse
transcription was performed as described in previous
chapter. qRT-PCR was then performed on cDNA using the
following primers Hs_CXCL12_1_SG, Hs_CXCR4_1_SG,
and Hs_NOS3_1_SG, which encodes for human SDF-1α,
CXCR4, and eNOS, respectively. Fold change in mRNA
expression relative to the untransfected control was calcu-
lated using the 2−ΔΔCT method  from averages of three
samples for each group. GAPDH (Hs_GAPDH_1_SG) was
used as the housekeeping gene.
2.6.3 Immunoﬂuorescent imaging
After 14 days of culture, samples were processed for
immunoﬂuorescent imaging. Brieﬂy, the samples were ﬁrst
washed with PBS and ﬁxed in 10% neutral buffered for-
malin for 20 min, and then processed using the standard
protocol for parafﬁnization. The samples were then cut into
8-μm thick slices, deparafﬁnized, and mounted on slides.
Prior to staining, the cells were permeabilized with 0.2%
Tween®20 (Sigma-Aldrich, France) solution in 1x PBS for
30 min (10 min wash × 3) and blocked using 10% normal
goat serum (Invitrogen, UK)/5% BSA/0.3 M glycine (pre-
pared in permeabilizing solution) for 1 h to inhibit non-
speciﬁc protein interaction. The slides were then stained
using monoclonal antibodies of CD31 (1:50; ab119339,
Abcam, UK) and SDF-1α(1:100; ab155090, Abcam, UK)
to visualize endothelial morphogenesis and compare the
expression of SDF-1αproteins, respectively.
The next day, the slides were rinsed in PBS thrice for
2–3 min each to remove any unbound primary antibodies.
Subsequently, the slides were incubated in either Alexa 488-
conjugated goat anti-mouse IgG (A32723, Invitrogen, UK) or
Alexa 594-conjugated goat anti-rabbit IgG (A11012, Invi-
trogen, UK) at 1:800 dilution at room temperature for 1 h in
dark. The rinsing step was performed as before and stained
for nuclei using the mounting medium with DAPI (ab104139,
Abcam, UK) and covered with cover slips. Images were then
captured using ﬂuorescence microscope (Olympus BX43,
Japan) at 40× magniﬁcation. Samples incubated with only
secondary antibodies were used as controls. All the antibodies
were diluted in 1% BSA in PBS prior to use.
2.6.4 Image analysis
The “ImageJ”software (ImageJ, NIH, Maryland, USA) was
used to semiquantitatively determine the amount of
expressed proteins. For each marker, a constant threshold
value was ﬁrst determined through preliminary imaging of
various sections. Using the set threshold value, integrated
density (stained area × mean gray value) of the images was
determined and then normalized to the number of cells
(DAPI counting) to give a ﬁnal mean ﬂuorescence density
per cell. An average was quantiﬁed from four to ﬁve ran-
dom images per sample, with a minimum of three samples
per group. The averages obtained from each group were
then used for statistical comparisons between the groups.
2.6.5 Bioactivity analysis of secreted factors from coculture
on SDF-1αGAS on human SCs
In order to study if the vascularized construct possesses
proneurogenic properties, CM (day 7) collected from the
coculture groups was exposed to human SCs (iXCells Bio-
technologies, USA). Human SCs at passages 3 and 4 were
seeded onto poly-l-lysine (P4707, Sigma, UK) coated 12-
well plates at a density of 30,000 cells/well and allowed to
grow until conﬂuency. Injury was made to the monolayer of
SCs by creating a scratch using a sterile 200 μl pipette tip.
The cells were gently rinsed with PBS to remove any cellular
debris and treated with CM from the vascularized constructs.
Cellular organization was then observed until 48 h. Quanti-
ﬁcation of the cellular area was performed using ImageJ from
at least ﬁve images per well (n=3).
2.7 Statistical analysis
All results are expressed as mean ± standard deviation.
Unpaired, two-tailed, t-test was used to demonstrate the
statistical signiﬁcance between groups, where p< 0.05 was
26 Page 4 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
considered to be signiﬁcant. One-way ANOVA was also
used to compare statistical difference between the multiple
groups, considering p< 0.05 to be signiﬁcant.
3.1 PEI–pSDF-1αpolyplex effectively transfected
HUVECs and induced the secretion of functional
MTS assay showed that at days 3 and 7, HUVECs transfected
with PEI–pSDF-1αsigniﬁcantly promoted their survivability
than the groups transfected with polyplex carrying the non-
therapeutic gene, pLuc (Fig. 1A). Subsequent SDF-1αELISA
analysis showed that protein production reached the max-
imum (565 ± 35 pg/ml) on the 7th day but dropped sig-
niﬁcantly (p< 0.001) at later time points (Fig. 1B). Prior to the
addition of ADSCs, HUVECs secreted comparable levels of
SDF-1α(530 ± 95 pg/ml) as HUVECs monoculture group.
However, SDF-1αprotein levels in the CM were not detect-
able on the days after the HUVECs were cocultured with
ADSCs. Furthermore, on the 14th day, phase-contrast
microscopy revealed that the transfected HUVECs when
cocultured with ADSCs displayed the formation of elongated
cellular clusters with cellular extensions appearing out of the
cluster in multiple directions (Fig. 1C-iv). The untransfected
coculture group also exhibited the formation of interconnected
cellular network. However, cobblestone-like morphological
features of the individual endothelial cells remained distin-
guishable (Fig. 1C-iii). Clearly, morphological differences
between the coculture groups suggest that PEI–pSDF-1α
transfected HUVECs secrete functional proteins capable of
recruiting ADSCs for enhanced functional interaction.
3.2 SDF-1αGAS effectively engages endothelial VE-
cadherin while promoting angiogenesis
Angiogenesis is a dynamic process that occurs through
transient disruption of the endothelial adherent junctions
. During the junctional disruption, the adhesion mole-
cules, primarily the VE-cadherin is released as a soluble
form . Therefore, in order to measure angiogenesis
within the SDF-1αGAS, we assayed soluble VE-cadherin
released during the culture period (Fig. 2). All the groups
demonstrated a transient trend in the release of soluble VE-
cadherin that peaked at day 10. Among the groups,
HUVECs on gene-free scaffold released the highest amount
of VE-cadherin at all time points (up to 5.83 ± 0.3 ng/ml at
day 10). When ADSCs were added to the preformed
endothelial network, the release of soluble VE-cadherin was
strongly attenuated. However, we noted a similar amount of
VE-cadherin released by the HUVECs on SDF-1αGAS as
that of the coculture on the gene-free scaffold. Considering
the impact of SDF-1αGAS on HUVECs, we anticipated
more pronounced attenuation of VE-cadherin release in the
coculture on SDF-1αGAS. We conﬁrmed this event by
measuring the level of VE-cadherin from the coculture on
SDF-1αGAS, which showed the lowest (1.27 ± 0.45 ng/ml
at day 10) at all time points. Taken together, it implies that
SDF-1αGAS engages the endothelial VE-cadherin to
modulate angiogenesis in a transient manner.
The release of soluble VE-cadherin could also be mediated
by inﬂammation and its level corresponds to the degree of
inﬂammation [38,39]. Therefore, having observed high level
of soluble VE-cadherin with HUVECs on gene-free scaffold,
we assessed if vascular inﬂammation was involved. This was
conducted by measuring the release of inﬂammation-
associated soluble VCAM-1 . In all the groups, no
detectable amounts of soluble VCAM-1 were released, sup-
porting the notion that the release of VE-cadherin was a
physiological process to promote angiogenesis.
3.3 Coculture enhances SDF-1α-mediated
provasculogenic gene expression
Having noted that cultures on SDF-1αGAS effectively pre-
serve endothelial junctional integrity during angiogenesis, gene
expression was performed at day 14 to determine endothelial
maturation (Fig. 3). First, we measured the levels of SDF-1α
mRNA and noted that coculturing with ADSCs enhances the
expression of SDF-1αmRNA than HUVECs alone. The
coculture on the gene-free scaffold expressed the SDF-1α
mRNA twice as high as HUVECs on the SDF-1αGAS. A
more pronounced expression was noted in the coculture on the
SDF-1αGAS that showed an eightfold higher expression of
the SDF-1αmRNA than its gene-free equivalent.
Provasculogenic maturation was then determined based
on the expression of SDF-1α’s downstream effector
mRNAs, namely CXCR4 and eNOS. We noted that the
SDF-1αGAS is not sufﬁciently potent to drive HUVECs
toward a provasculogenic maturation. The SDF-1αGAS
caused a modest increase (43%) in the expression of eNOS
in HUVECs. However, coculturing with ADSCs sig-
niﬁcantly upregulated the expression of eNOS than the
HUVECs on SDF-1αGAS. Furthermore, the coculture on
SDF-1αGAS exhibited a sixfold higher expression of
eNOS mRNA than the HUVECs on the SDF-1αGAS. This
ﬁnding suggests that coculture is crucial for enhancing
endothelial maturation in SDF-1αGAS.
3.4 SDF-1αGAS supports endothelial
Immunostaining with the primary marker for endothelial
cells CD31 revealed that all the groups had undergone
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 5 of 13 26
morphogenesis representative of a capillary-like network
(Fig. 4A). Having conﬁrmed this, SDF-1αwas double
immunostained with CD31 (Fig. 4B, C) to visualize its
spatial distribution on the cellular surface as well as the
level of expression. Mean ﬂuorescence density analysis of
SDF-1αrevealed a progressive increase in the expression of
SDF-1αfrom the monocultures of HUVECs toward the
coculture group (Fig. 4D). However, no signiﬁcant differ-
ence was noted between HUVECs on the SDF-1αGAS and
the coculture groups. Only the coculture on SDF-1αGAS
exhibited signiﬁcantly higher levels of SDF-1αthan the
HUVECs on the gene-free scaffold. Spatially, the SDF-1α
Fig. 1 Effect of PEI–pSDF-1αtransfection on HUVECs and its impact
on ADSCs. APEI–pSDF-1αtransfected HUVECs exhibited sig-
niﬁcantly enhanced survivability response compared to those trans-
fected nontherapeutic PEI–pLuc polyplex. BTransfection with
PEI–pSDF-1αinduced transient production of the target protein over a
period of 2 weeks. CPhase-contrast microscopy images of morpho-
logical changes in HUVECs and its coculture with ADSCs at day 14. i
Untransfected HUVECs maintained its cobblestone-like morphology.
ii Transfected HUVECs appeared more polarized. iii Addition of
ADSCs to untransfected HUVECs resulted in the formation of inter-
connected cellular network within the monolayer assembly. iv Elon-
gated, pseudo three-dimensional dense cellular clusters were formed in
transfected coculture group. Data are plotted as mean ± standard
26 Page 6 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
in HUVECs on SDF-1αGAS appears to be bound to the
cellular surface (indicated by arrows, Fig. 4C-ii). On the
other hand, SDF-1αin coculture on SDF-1αGAS appears
to be secreted into the extracellular space (indicated by
arrows, Fig. 4C-iv). Overall, this ﬁnding demonstrates that
SDF-1αGAS effectively supports angiogenesis and that
coculture enhances SDF-1αprotein expression.
3.5 Coculture on SDF-1αGAS induces human SCs
In addition to vasculogenesis, neuronal regeneration is an
important aspect of wound healing that is often over-
looked. During angiogenesis, the angiogenic vessels guide
the SCs to the site of wound . The SCs then lay down
matrix to guide regenerating axons and promote their
reinnervation of the epidermis . Therefore, having
observed enhanced vasculogenic response in the coculture
groups, the potential of the vascularized constructs to
signal SCs was investigated.
Twenty-four hours post exposure to CM, the SCs
actively invaded the wound zone regardless of the source of
the CM (Fig. 5B). However, further incubation of the SCs
in the CM up to 48 h resulted in the generation of cluster-
like structures (Fig. 5C). These clusters formed connections
between other clusters through slender cord-like structures
that protruded out of each clusters. The clusters did not have
deﬁned boundaries however measurement of the total spa-
tial coverage revealed that the CM from coculture on SDF-
1αGAS generated signiﬁcantly larger SCs clusters than the
CM from its gene-free equivalent (Fig. 5C-ii). In addition,
the cord-like structures connecting the large clusters were
highly aligned and more parallelly arranged than the con-
nections between the smaller clusters (Fig. 5C-ii). From
these observations, it is evident that vascularized SDF-1α
GAS produces signaling components that can stimulate
proneurogenic behavior in SCs implicated for neuronal
The overall objective of the study was to assess the bioac-
tivity of SDF-1αGAS on human endothelial cells and its
coculture with human ADSCs. A preliminary 2D study
showed that the HUVECs transfected with PEI–pSDF-1α
polyplex transiently secreted SDF-1αproteins that actively
recruited ADSCs and enhanced their adhesion to the
HUVECs. On the SDF-1αGAS, the HUVECs displayed
angiogenesis that occurred in a transient manner through
regulation of the junctional adhesion molecule VE-
cadherin. Coculturing with ADSCs signiﬁcantly improved
the preservation of the VE-cadherin and also enhanced the
maturation of endothelial cells through the expression of
downstream effectors CXCR4 and eNOS. Secreted factors
from the provasculogenic vessels on SDF-1αGAS further
displayed strong bioactive properties toward human SCs
that organized into Bünger band-like structures. Together,
this study showed that SDF-1αGAS is a highly functional
biomaterial scaffold capable of enhancing provasculogenic
response for wound healing applications.
In the application of synthetic gene-delivery vectors, the
survivability of the cells post transfection is critical for
offering the optimal therapeutic response [41–43]. There-
fore, we ﬁrst evaluated the safety of the polyplexes on the
HUVECs. First, we noted a proliferation curve that peaked
at day 3. This appears to be a general manner of pro-
liferation of HUVECs in EGM, as a similar case has been
observed in other studies, which validated the behavior
through the measurement of proliferation marker Ki67 .
Nevertheless, our ﬁnding indicates that despite an initial
insult to HUVECs’health due to the exposure to poly-
plexes, the delivery of SDF-1αgene signiﬁcantly enhanced
the survivability of HUVECs than the ones transfected with
Luc gene (Fig. 1A). This ﬁnding possibly suggests that
secreted SDF-1αproteins may have exerted a protective
effect on the HUVECs itself, mediated by a positive auto-
crine loop . Our analysis of SDF-1αprotein production
further proved that the transfected HUVECs indeed pro-
duced high levels of SDF-1αprotein that lasted up to
14 days (Fig. 1B). We further conﬁrmed that SDF-1αpro-
tein was also highly bioactive toward the ADSCs as a
greater clustering of the cells occurred in the coculture
Fig. 2 Temporal regulation of soluble VE-cadherin from endothelia-
lized gene-free scaffold and SDF-1αGAS. SDF-1αGAS strongly
affects the vascular growth of endothelial cells by suppressing the
release of soluble VE-cadherin. Coculturing with ADSCs offers further
control on the release of soluble VE-cadherin from endothelial cells.
HUVECs on SDF-1αGAS demonstrated signiﬁcant reduction in the
levels of soluble VE-cadherin at days 7 (p< 0.05) and 10 (p< 0.0005)
relative to HUVECs on gene-free scaffold. Coculture on SDF-1αGAS
strongly attenuated the release of VE-cadherin at all time points. Data
are presented as mean ± standard deviation. One-way ANOVA was
used to deduce statistical signiﬁcance. *, **, ***, and **** indicate
statistical signiﬁcance of p< 0.05, p< 0.01, p< 0.005, and p< 0.0005,
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 7 of 13 26
group consisting of SDF-1αproducing HUVECs. The
response to SDF-1αis potentially mediated by CXCR4 in
ADSCs that play a speciﬁc role in SDF-1αdriven chemo-
Normally, to measure angiogenesis on 3D scaffolds over
time, the endothelialized constructs are harvested at pre-
speciﬁed time points and imaged for capillary-like network
formation [14,25]. Here, we show a relatively simpler
alternative method that allows continuous monitoring of the
endothelial growth in a 3D scaffold without the need for
harvesting the cellularized samples. This technique also
offers another advantage by providing information of the
dynamic changes in endothelial junctional stability, which
is crucial for endothelial homeostasis [36,47]. Based on a
previous study , which described that the endothelial
junctional adhesion molecule VE-cadherin is proteolytically
cleaved during angiogenesis and shed as a soluble form, we
measured the amount of VE-cadherin released from the
endothelialized constructs. The HUVECs on the gene-free
scaffold showed a clear transient release of the soluble VE-
cadherin that peaked at day 10. This ﬁnding conﬁrms that
the VE-cadherin is temporally involved in endothelial
angiogenesis. Furthermore, the pattern of VE-cadherin
release is also in agreement with ﬁndings of both in vitro
[14,25] and in vivo  studies, which showed that the
angiogenesis peaks between days 7 and 14. Moreover,
comparing the levels of VE-cadherin revealed a potential
role of SDF-1αGAS that it may be involved in the
enhancement of homophilic endothelial-to-endothelial
adhesion mediated by VE-cadherin . This speculation
is derived from the ﬁnding that the HUVECs on SDF-1α
GAS released similar levels of VE-cadherin as that of the
coculture on the gene-free scaffold. The cocultures are
generally known to enhance the expression of cellular VE-
cadherin and engage them in the restoration of endothelial
barrier functions [50–52].
Fig. 3 Gene expression analysis of HUVECs and its coculture on
gene-free scaffolds and SDF-1αGAS. SDF-1αGAS signiﬁcantly
increased the expression of mRNAs for SDF-1αand its cognate
receptor CXCR4 in HUVECs. Coculture with ADSCs signiﬁcantly
elevated the expression of downstream effector genes of SDF-1α—
CXCR4 and eNOS than the HUVECs on SDF-1αGAS. Data are
plotted as mean ± standard deviation (n=3). *, **, and *** indicate
statistical signiﬁcance of p< 0.05, p< 0.01, and p< 0.005, respectively
26 Page 8 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
The signiﬁcant activation of CXCR4 in the HUVECs on
SDF-1αGAS presents a potential mechanism that may have
controlled the release of VE-cadherin from the HUVECs. The
SDF-1α-induced CXCR4 may sustain the expression of VE-
cadherin and maintain the endothelial barrier functions via the
activation of Wnt/β-catenin pathway . The stem cells are
VE-cadherin-mediated barrier properties of endothelial cells
. Importantly, gene expression analysis further showed
that the SDF-1αGAS alone is insufﬁcient to drive pro-
vasculogenic response in HUVECs and that coculturing with
ADSCs was crucial for enhancement of the provasculogenic
gene eNOS. Similar enhancement in the expression of eNOS
mRNA in the coculture of endothelial cells and ADSCs has
Fig. 4 Visualization of
endothelial anastomosis and
SDF-1αexpression. AAll the
cultures showed strong
immunoreactivity to CD31 and
morphogenesis representative of
BHUVECs on the gene-free
scaffold expressed the lowest
amount of SDF-1αproteins.
CMagniﬁed images of the
endothelial network showing the
differences in spatial distribution
of SDF-1αbetween the groups.
DQuantitative representation of
showing an increasing trend
toward the coculture group. Data
are presented as mean ± standard
deviation. * indicates statistical
signiﬁcance of p< 0.05
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 9 of 13 26
also been observed in other studies . Although we
investigated this study as an approach for enhancing blood
vessel regeneration in a biomaterial scaffold, SDF-1αGAS
may also be useful for promoting lymphangiogenesis. The
lymphatic vessels regulate immune cell trafﬁcking and tissue
ﬂuid homeostasis . In addition to angiogenesis, lym-
phangiogenesis also actively participates in the wound healing
process and relies on the growth of lymphatic endothelial cells
(LECs) . VEGF-C is a potent stimulant of LECs .
However, similar to angiogenesis, studies have found that the
interaction of LECs with stem cells is crucial for expanding
the lymphatic endothelial network [57,58]. Moreover, the
ADSCs, despite the low production of VEGF-C, were
found to enhance the growth of LECs effectively .
Fig. 5 Cellular organization of
human Schwann cells in
response to CM derived from
coculture of endothelial cells
and ADSCs. AA scratched
monolayer of Schwann cells.
BSchwann cells invading the
wounded zone 24 h post
exposure to CM. CSchwann
cells undergoing morphological
changes 48 h post exposure to
CM. DAt 48 h, Schwann cells
exposed to CM from the
coculture on SDF-1αGAS
organized into signiﬁcantly (p<
0.01) larger interconnected
clusters than the Schwann cells
exposed to CM from the
coculture on gene-free scaffold.
Data are presented as mean ±
26 Page 10 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
Therefore, given the importance of endothelial cells’interac-
tion with stem cells for lymphangiogenesis, the ability of
SDF-1αGAS to induce the overexpression of chemotactic
SDF-1αmay facilitate improved intercellular interaction and
enhance functional growth.
In order to readdress the importance of neuronal activa-
tion while considering strategies for wound healing, we
ultimately investigated if the provasculogenic coculture
constructs can signal SCs. SCs were speciﬁcally chosen
because, in the process of reinnervation, SCs invasion
precedes axonal regeneration [60,61]. During angiogenesis,
invading blood vessels guide the SCs into the wound site
[31,61]. The SCs then lay down matrix and guide the
regenerating axons for epidermal reinnervation .
We validated that the CM produced by the coculture on
the SDF-1αGAS possessed superior bioactive properties
than its gene-free scaffold equivalent. However, an apparent
difference in the response of SCs appeared only at 48 h post
exposure to CM. The SCs exposed to CM from the SDF-1α
GAS group grew into signiﬁcantly large clusters. Clusters
incubated in the CM from the SDF-1αGAS group also
developed parallelly arranged cord-like structures connect-
ing other clusters. This cellular arrangement has also been
demonstrated by SCs when they were cocultured with
neural cells such as the meningeal cells [62,63]. These
cellular arrangement are presumed a transformation of the
SCs into Bünger bands, which is necessary for supporting
axonal regeneration across wound [32,62].
To this end, we show that the provasculogenic structures
created on SDF-1αGAS are highly potent bioactive con-
structs for wound healing applications. Nevertheless, it
would be interesting to see how the SDF-1αGAS might
work on adult endothelial cells such as the peripheral blood
or umbilical cord blood-derived endothelial cells (ECFCs)
 and the induced pluripotent stem cells derived endo-
thelial cells (iPSCs-ECs) . Both ECFCs and iPSCs are
known to show high proangiogenic activity both in vitro
 and in vivo [64,65]. Moreover, ECFCs are also known
to possess stem cell-like properties , which may offer
enhanced therapeutic effects. These cell types are of parti-
cular interest as they can be harvested from the patient and
representing clinically translatable cell candidates for
autologous therapy [68,69]. In the future, we will further
attempt to investigate the efﬁcacy of the prevascularized
construct in vivo, which is currently a limitation of the
study, using established techniques such as subcutaneous
implantation in nude mice.
This study explored the functional impact of SDF-1αGAS
on human endothelial cells and its coculture with human
ADSCs. Particularly, we have shown that SDF-1αGAS
effectively supports endothelial angiogenesis by desirably
controlling the junctional adhesive effect, which is essential
for maturation of the endothelial network. Better maturation
could be achieved through coculturing with ADSCs, which
was further enhanced when supported with SDF-1αGAS.
In addition, SDF-1αGAS activated coculture group
demonstrated a strong capacity to signal SCs to differentiate
toward a proneurogenic phenotype by inﬂuencing their
cellular organization into Bünger band-like structures.
Taken together, we showed a potent bioinstructive role of
SDF-1αGAS for the generation of bioactive provasculo-
genic constructs for enhanced wound healing applications.
Acknowledgements This work was funded by RCSI-Dilmun PhD
Compliance with ethical standards
Conﬂict of interest The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional afﬁliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if
changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.
1. West JL, Moon JJ. Vascularization of engineered tissues:
approaches to promote angiogenesis in biomaterials. Curr Top
Med Chem. 2008;8:300–10.
2. Quinlan E, López‐Noriega A, Thompson EM, Hibbitts A, Cryan SA,
O’Brien FJ. Controlled release of vascular endothelial growth factor
from spray‐dried alginate microparticles in collagen–hydroxyapatite
scaffolds for promoting vascularization and bone repair. J Tissue Eng
Regen Med. 2017;11:1097–109.
3. Losi P, Briganti E, Errico C, Lisella A, Sanguinetti E, Chiellini F,
et al. Fibrin-based scaffold incorporating VEGF-and bFGF-loaded
nanoparticles stimulates wound healing in diabetic mice. Acta
4. Kanda N, Morimoto N, Ayvazyan AA, Takemoto S, Kawai K,
Nakamura Y, et al. Evaluation of a novel collagen–gelatin scaffold
for achieving the sustained release of basic ﬁbroblast growth factor
in a diabetic mouse model. J Tissue Eng Regen Med. 2014;8:29–40.
5. Laiva AL, O’Brien FJ, Keogh MB. Innovations in gene and
growth factor delivery systems for diabetic wound healing. J
Tissue Eng Regen Med. 2018;12:e296–312.
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 11 of 13 26
6. Davies NH, Schmidt C, Bezuidenhout D, Zilla P. Sustaining
neovascularization of a scaffold through staged release of vascular
endothelial growth factor-A and platelet-derived growth factor-
BB. Tissue Eng Part A. 2011;18:26–34.
7. Wang Z, Wang Z, Lu WW, Zhen W, Yang D, Peng S. Novel
biomaterial strategies for controlled growth factor delivery for
biomedical applications. NPG Asia Mater. 2017;9:e435.
8. Lloyd-Grifﬁth C, McFadden TM, Duffy GP, Unger RE,
Kirkpatrick CJ, O’Brien FJ. The pre-vascularisation of a collagen-
chondroitin sulphate scaffold using human amniotic ﬂuid-derived
stem cells to enhance and stabilise endothelial cell-mediated
vessel formation. Acta Biomater. 2015;26:263–73.
9. Duffy GP, McFadden TM, Byrne EM, Gill S-L, Farrell E, O’Brien
FJ. Towards in vitro vascularisation of collagen-GAG scaffolds.
Eur Cell Mater. 2011;21:e30.
10. McFadden T, Duffy G, Allen A, Stevens H, Schwarzmaier S,
Plesnila N, et al. The delayed addition of human mesenchymal
stem cells to pre-formed endothelial cell networks results in
functional vascularization of a collagen–glycosaminoglycan
scaffold in vivo. Acta Biomater. 2013;9:9303–16.
11. Zhang W, Wray LS, Rnjak-Kovacina J, Xu L, Zou D, Wang S,
et al. Vascularization of hollow channel-modiﬁed porous silk
scaffolds with endothelial cells for tissue regeneration. Bioma-
12. Unger RE, Ghanaati S, Orth C, Sartoris A, Barbeck M, Halstenberg S,
et al. The rapid anastomosis between prevascularized networks on silk
ﬁbroin scaffolds generated in vitro with cocultures of human micro-
vascular endothelial and osteoblast cells and the host vasculature.
13. Kress S, Baur J, Otto C, Burkard N, Braspenning J, Walles H,
et al. Evaluation of a miniaturized biologically vascularized
scaffold in vitro and in vivo. Sci Rep. 2018;8:4719.
14. do Amaral RJFC, Cavanagh B, O’Brien FJ, Kearney CJ. Plate-
let‐derived growth factor stabilises vascularisation in
collagen–glycosaminoglycan scaffolds in vitro. J Tissue Eng
Regen Med. 2019;13:261–73.
15. Raftery RM, Castaño IM, Chen G, Cavanagh B, Quinn B, Curtin
CM, et al. Translating the role of osteogenic-angiogenic coupling
in bone formation: Highly efﬁcient chitosan-pDNA activated
scaffolds can accelerate bone regeneration in critical-sized bone
defects. Biomaterials. 2017;149:116–27.
16. Curtin CM, Tierney EG, McSorley K, Cryan SA, Duffy GP,
O’Brien FJ. Combinatorial gene therapy accelerates bone
regeneration: non‐viral dual delivery of VEGF and BMP2 in a
collagen‐nanohydroxyapatite scaffold. Adv Health Mater.
17. Raftery RM, Walsh DP, Ferreras LB, Castaño IM, Chen G,
LeMoine M, et al. Highly versatile cell-penetrating peptide loaded
scaffold for efﬁcient and localized gene delivery to multiple cell
types: from development to application in tissue engineering.
18. Lackington WA, Raftery RM, O’Brien FJ. In vitro efﬁcacy of a
gene-activated nerve guidance conduit incorporating non-viral
PEI-pDNA nanoparticles carrying genes encoding for NGF,
GDNF and c-Jun. Acta Biomater. 2018;75:115–28.
19. Tierney EG, Duffy GP, Hibbitts AJ, Cryan S-A, O’Brien FJ. The
development of non-viral gene-activated matrices for bone
regeneration using polyethyleneimine (PEI) and collagen-based
scaffolds. J Control Release. 2012;158:304–11.
20. Laiva AL, Raftery RM, Keogh MB, O’brien FJ. Pro-angiogenic
impact of SDF-1αgene-activated collagen-based scaffolds in stem
cell driven angiogenesis. Int J Pharm. 2018;544:372–9.
21. Gallagher KA, Liu Z-J, Xiao M, Chen H, Goldstein LJ, Buerk
DG, et al. Diabetic impairments in NO-mediated endothelial
progenitor cell mobilization and homing are reversed by hyper-
oxia and SDF-1α. J Clin Investig. 2007;117:1249–59.
22. Yu J, Sievers RE, Lee RJ. Effects of scaffold-delivered SDF-1
alpha protein in chronic rat myocardial infarction model. J Med
Biol Eng. 2014;34:224–9.
23. Rabbany SY, Pastore J, Yamamoto M, Miller T, Raﬁi S, Aras R,
et al. Continuous delivery of stromal cell-derived factor-1 from
alginate scaffolds accelerates wound healing. Cell Transplant.
24. Kuraitis D, Zhang P, Zhang Y, Padavan D, McEwan K,
Sofrenovic T, et al. A stromal cell-derived factor-1 releasing matrix
enhances the progenitor cell response and blood vessel growth in
ischaemic skeletal muscle. Eur Cell Mater. 2011;22:e23.
25. Freiman A, Shandalov Y, Rozenfeld D, Shor E, Segal S, Ben-
David D, et al. Adipose-derived endothelial and mesenchymal
stem cells enhance vascular network formation on three-
dimensional constructs in vitro. Stem Cell Res Ther. 2016;7:5.
26. Liu S, Zhang H, Zhang X, Lu W, Huang X, Xie H, et al.
Synergistic angiogenesis promoting effects of extracellular matrix
scaffolds and adipose-derived stem cells during wound repair.
Tissue Eng Part A. 2010;17:725–39.
27. Mazzocchi AR, Man AJ, DesOrmeaux J-PS, Gaborski TR. Porous
membranes promote endothelial differentiation of adipose-derived
stem cells and perivascular interactions. Cell Mol Bioeng.
28. Deng M, Gu Y, Liu Z, Qi Y, Ma GE, Kang N. Endothelial dif-
ferentiation of human adipose-derived stem cells on polyglycolic
acid/polylactic acid mesh. Stem Cells Int. 2015;2015:1–11.
29. Jabbarzadeh E, Starnes T, Khan YM, Jiang T, Wirtel AJ, Deng M,
et al. Induction of angiogenesis in tissue-engineered scaffolds
designed for bone repair: a combined gene therapy–cell transplan-
tation approach. Proc Natl Acad Sci USA. 2008;105:11099–104.
30. Jessen K, Mirsky R. The repair Schwann cell and its function in
regenerating nerves. J Physiol. 2016;594:3521–31.
31. Cattin A-L, Burden JJ, Van Emmenis L, Mackenzie FE, Hoving
JJ, Calavia NG, et al. Macrophage-induced blood vessels guide
Schwann cell-mediated regeneration of peripheral nerves. Cell.
32. Parrinello S, Napoli I, Ribeiro S, Digby PW, Fedorova M,
Parkinson DB, et al. EphB signaling directs peripheral nerve
regeneration through Sox2-dependent Schwann cell sorting. Cell.
33. Ramos T, Ahmed M, Wieringa P, Moroni L. Schwann cells pro-
mote endothelial cell migration. Cell Adhes Migr. 2015;9:441–51.
34. Haugh MG, Murphy CM, O’Brien FJ. Novel freeze-drying
methods to produce a range of collagen–glycosaminoglycan
scaffolds with tailored mean pore sizes. Tissue Eng Part C:
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression
data using real-time quantitative PCR and the 2−ΔΔCT method.
36. Di Lorenzo A, Lin MI, Murata T, Landskroner-Eiger S, Schleicher
M, Kothiya M, et al. eNOS-derived nitric oxide regulates endo-
thelial barrier function through VE-cadherin and Rho GTPases. J
Cell Sci. 2013;126:5541–52.
37. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP,
Saftig P, et al. ADAM10 regulates endothelial permeability and T-
cell transmigration by proteolysis of vascular endothelial cadherin.
Circ Res. 2008;102:1192–201.
38. Sidibé A, Mannic T, Arboleas M, Subileau M, Gulino‐Debrac D,
Bouillet L, et al. Soluble VE‐cadherin in rheumatoid arthritis
patients correlates with disease activity: evidence for tumor
necrosis factor α–induced VE‐cadherin cleavage. Arthritis Rheum.
39. Flemming S, Burkard N, Renschler M, Vielmuth F, Meir M,
Schick MA, et al. Soluble VE-cadherin is involved in endothelial
barrier breakdown in systemic inﬂammation and sepsis. Cardio-
vasc Res. 2015;107:32–44.
26 Page 12 of 13 Journal of Materials Science: Materials in Medicine (2021) 32:26
40. Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead
RH, et al. Stimulated shedding of vascular cell adhesion molecule
1 (VCAM-1) is mediated by tumor necrosis factor-α-converting
enzyme (ADAM 17). J Biol Chem. 2003;278:37459–64.
41. Ahn HH, Lee JH, Kim KS, Lee JY, Kim MS, Khang G, et al.
Polyethyleneimine-mediated gene delivery into human adipose
derived stem cells. Biomaterials. 2008;29:2415–22.
42. Hunt MA, Currie MJ, Robinson BA, Dachs GU. Optimizing
transfection of primary human umbilical vein endothelial cells
using commercially available chemical transfection reagents. J
Biomol Tech. 2010;21:66.
43. Forcato D, Fili A, Alustiza F, Martínez JL, Abel SB, Nicotra MO,
et al. Transfection of bovine fetal ﬁbroblast with polyethylenimine
(PEI) nanoparticles: effect of particle size and presence of fetal
bovine serum on transgene delivery and cytotoxicity. Cyto-
44. Gharaei M, Xue Y, Mustafa K, Lie S, Fristad I. Human dental
pulp stromal cell conditioned medium alters endothelial cell
behavior. Stem Cell Res Ther. 2018;9:69.
45. Cho S-W, Yang F, Son SM, Park H-J, Green JJ, Bogatyrev S,
et al. Therapeutic angiogenesis using genetically engineered
human endothelial cells. J Control Release. 2012;160:515–24.
46. Li Q, Zhang A, Tao C, Li X, Jin P. The role of SDF-1-CXCR4/
CXCR7 axis in biological behaviors of adipose tissue-derived
mesenchymal stem cells in vitro. Biochem Biophys Res Commun.
47. Giannotta M, Trani M, Dejana E. VE-cadherin and endothelial
adherens junctions: active guardians of vascular integrity. Dev
48. Shaterian A, Borboa A, Sawada R, Costantini T, Potenza B,
Coimbra R, et al. Real-time analysis of the kinetics of angiogen-
esis and vascular permeability in an animal model of wound
healing. Burns. 2009;35:811–7.
49. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens
junctions and VE-cadherin in the control of vascular permeability.
J Cell Sci. 2008;121:2115–22.
50. Grainger SJ, Putnam AJ. Assessing the permeability of engineered
capillary networks in a 3D culture. PLoS ONE. 2011;6:e22086.
51. Pati S, Khakoo AY, Zhao J, Jimenez F, Gerber MH, Harting M,
et al. Human mesenchymal stem cells inhibit vascular perme-
ability by modulating vascular endothelial cadherin/β-catenin
signaling. Stem Cells Dev. 2010;20:89–101.
52. Chen Q-H, Liu A-R, Qiu H-B, Yang Y. Interaction between
mesenchymal stem cells and endothelial cells restores endothelial
permeability via paracrine hepatocyte growth factor in vitro. Stem
Cell Res Ther. 2015;6:44.
53. Döring Y, Noels H, van der Vorst EP, Neideck C, Egea V,
Drechsler M, et al. Vascular CXCR4 limits atherosclerosis by
maintaining arterial integrity: evidence from mouse and human
studies. Circulation. 2017;136:388–403.
54. Gao P, Yang X, Mungur L, Kampo S, Wen Q. Adipose tissue-
derived stem cells attenuate acute lung injury through eNOS and
eNOS-derived NO. Int J Mol Med. 2013;31:1313–8.
55. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechan-
isms and future promise. Cell. 2010;140:460–76.
56. Güç E, Briquez PS, Foretay D, Fankhauser MA, Hubbell JA,
Kilarski WW, et al. Local induction of lymphangiogenesis with
engineered ﬁbrin-binding VEGF-C promotes wound healing by
increasing immune cell trafﬁcking and matrix remodeling. Bio-
57. Saijo H, Suzuki K, Yoshimoto H, Imamura Y, Yamashita S,
Tanaka K. Paracrine effects of adipose-derived stem cells promote
lymphangiogenesis in irradiated lymphatic endothelial cells. Plast
Reconstr Surg. 2019;143:1189e–200e.
58. Knezevic L, Schaupper M, Mühleder S, Schimek K, Hasenberg T,
Marx U, et al. Engineering blood and lymphatic microvascular
networks in ﬁbrin matrices. Front Bioeng Biotechnol. 2017;5:25.
59. Ahmadzadeh N, Robering JW, Kengelbach-Weigand A, Al-
Abboodi M, Beier JP, Horch RE, et al. Human adipose-derived
stem cells support lymphangiogenesis in vitro by secretion of
lymphangiogenic factors. Exp Cell Res. 2020;388:111816.
60. Gingras M, Paradis I, Berthod F. Nerve regeneration in a
collagen–chitosan tissue-engineered skin transplanted on nude
mice. Biomaterials. 2003;24:1653–61.
61. Rajan B, Polydefkis M, Hauer P, Grifﬁn JW, McArthur JC.
Epidermal reinnervation after intracutaneous axotomy in man. J
Comp Neurol. 2003;457:24–36.
62. Franssen EH, Roet KC, de Bree FM, Verhaagen J. Olfactory
ensheathing glia and Schwann cells exhibit a distinct interaction
behavior with meningeal cells. J Neurosci Res. 2009;87:1556–64.
63. Roet KC, Wirz KT, Franssen EH, Verhaagen J. A role for neu-
ropilins in the interaction between Schwann cells and meningeal
cells. PLoS ONE. 2014;9:e109401.
64. Au P, Daheron LM, Duda DG, Cohen KS, Tyrrell JA, Lanning
RM, et al. Differential in vivo potential of endothelial progenitor
cells from human umbilical cord blood and adult peripheral blood
to form functional long-lasting vessels. Blood. 2008;111:1302–5.
65. Clayton ZE, Tan RP, Miravet MM, Lennartsson K, Cooke JP,
Bursill CA, et al. Induced pluripotent stem cell-derived endo-
thelial cells promote angiogenesis and accelerate wound closure
in a murine excisional wound healing model. Biosci Rep.
66. Belair DG, Whisler JA, Valdez J, Velazquez J, Molenda JA,
Vickerman V, et al. Human vascular tissue models formed from
human induced pluripotent stem cell derived endothelial cells.
Stem Cell Rev Rep. 2015;11:511–25.
67. Guillevic O, Ferratge S, Pascaud J, Driancourt C, Boyer-Di-Ponio
J, Uzan G. A novel molecular and functional stemness signature
assessing human cord blood-derived endothelial progenitor cell
immaturity. PLoS ONE. 2016;11:e0152993.
68. Paschalaki KE, Randi AM. Recent advances in endothelial colony
forming cells toward their use in clinical translation. Front Med.
69. Haake K, Ackermann M, Lachmann N. Concise review: towards the
clinical translation of induced pluripotent stem cell‐derived blood
cells—ready for take‐off. Stem Cells Transl Med. 2019;8:332–9.
Journal of Materials Science: Materials in Medicine (2021) 32:26 Page 13 of 13 26
Terms and Conditions
Springer Nature journal content, brought to you courtesy of Springer Nature Customer Service Center GmbH (“Springer Nature”).
Springer Nature supports a reasonable amount of sharing of research papers by authors, subscribers and authorised users (“Users”), for small-
scale personal, non-commercial use provided that all copyright, trade and service marks and other proprietary notices are maintained. By
purposes, Springer Nature considers academic use (by researchers and students) to be non-commercial.
These Terms are supplementary and will apply in addition to any applicable website terms and conditions, a relevant site licence or a personal
subscription. These Terms will prevail over any conflict or ambiguity with regards to the relevant terms, a site licence or a personal subscription
(to the extent of the conflict or ambiguity only). For Creative Commons-licensed articles, the terms of the Creative Commons license used will
We collect and use personal data to provide access to the Springer Nature journal content. We may also use these personal data internally within
ResearchGate and Springer Nature and as agreed share it, in an anonymised way, for purposes of tracking, analysis and reporting. We will not
otherwise disclose your personal data outside the ResearchGate or the Springer Nature group of companies unless we have your permission as
While Users may use the Springer Nature journal content for small scale, personal non-commercial use, it is important to note that Users may
use such content for the purpose of providing other users with access on a regular or large scale basis or as a means to circumvent access
use such content where to do so would be considered a criminal or statutory offence in any jurisdiction, or gives rise to civil liability, or is
falsely or misleadingly imply or suggest endorsement, approval , sponsorship, or association unless explicitly agreed to by Springer Nature in
use bots or other automated methods to access the content or redirect messages
override any security feature or exclusionary protocol; or
share the content in order to create substitute for Springer Nature products or services or a systematic database of Springer Nature journal
In line with the restriction against commercial use, Springer Nature does not permit the creation of a product or service that creates revenue,
royalties, rent or income from our content or its inclusion as part of a paid for service or for other commercial gain. Springer Nature journal
content cannot be used for inter-library loans and librarians may not upload Springer Nature journal content on a large scale into their, or any
other, institutional repository.
content on this website and may remove it or features or functionality at our sole discretion, at any time with or without notice. Springer Nature
may revoke this licence to you at any time and remove access to any copies of the Springer Nature journal content which have been saved.
To the fullest extent permitted by law, Springer Nature makes no warranties, representations or guarantees to Users, either express or implied
with respect to the Springer nature journal content and all parties disclaim and waive any implied warranties or warranties imposed by law,
including merchantability or fitness for any particular purpose.
Please note that these rights do not automatically extend to content, data or other material published by Springer Nature that may be licensed
from third parties.
If you would like to use or distribute our Springer Nature journal content to a wider audience or on a regular basis or in any other manner not
expressly permitted by these Terms, please contact Springer Nature at